Abstract
Down syndrome (DS): or trisomy 21: is the most common autosomal aneuploidy and the leading genetic cause of intellectual disability. It is widely established that mental retardation is primarily a consequence of brain functioning and developmental abnormalities in neurogenesis. Some changes in the physical structure of the dendrites are a major cause of impaired synaptic plasticity of DS. The overexpression of the dual specificyty tyrsone phosphorylation-regulated kinase 1A (DYRK1A): located on chromosome 21: is involved in cellular plasticity and responsible for central nervous system disturbance in DS. Oleic acid is a neurotrophic factor that promotes neuronal differentiation and increases the levels of choline acetyltransferase (ChAT). Furthermore: it has recently been shown that it induces migration and formation of new synapses in euploid cells. However: remarkably oleic acid fails to reproduce the same effects in trisomic cells. Here we review the hypothesis that oleic acid-dependent synaptic plasticity may be dependent on the lipid environment. Thus: differences in membrane composition may be essential to understand why oleic acid promotes higher cell plasticity in euploid than in trisomic cells.
Highlights
Down syndrome (DS) is characterized by the presence of an extra copy of human chromosome 21 (HSA21)
CTb cells overexpress DS-related genes (Dyrk1A: App: Sod[1]: Cu/Zn superoxide dismutase) and show altered cholinergic function: involving reduced choline uptake and choline acetyltransferase (ChAT) expression: together with a fractional acetylcholine release after stimulation[19]. By using these cell lines: we previously showed that trisomic cells do not respond to the presence of oleic acid as euploid cells
Our results indicated that oleic acid induced the expression of ChAT in euploid cells: but not in trisomic cells[20]
Summary
Oleic Acid and Cholinergic dysfunction in Down Syndrome Models of the Central Nervous System. Departamento de Bioquímica y Biología Molecular: Instituto de Neurociencias de Castilla y León (INCYL): Universidad de Salamanca: Instituto de Investigación Biomédica de Salamanca (IBSAL): Spain
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have